Wang, Zhenping
Wang, Yanhan
Bradbury, Nicholas
Gonzales Bravo, Carolina
Schnabl, Bernd
Di Nardo, Anna
Article History
Received: 20 May 2020
Accepted: 23 November 2020
First Online: 10 December 2020
Competing interests
: Bernd Schnabl (co-author) has been consulting for Ferring Research Institute, Intercept Pharmaceuticals, HOST Therabiomics and Patara Pharmaceuticals. B.S.’s institution UC San Diego has received grant support from BiomX, NGM Biopharmaceuticals, CymaBay Therapeutics, Synlogic Operating Company and Axial Biotherapeutics. Zhenping Wang, Yanhan Wang, Nicholas Bradbury, Carolina Gonzales Bravo and Anna Di Nardo have NO conflict of interest to declare.